Scancell Holdings Share News (SCLP)

Oxford Technology VCTs Mostly Report Drop In Net Asset Value

LONDON (Alliance News) - The Oxford Technology-managed venture capital trusts reported interim results on Wednesday, with all but one see a drop in net asset value.Oxford Technology Venture

WINNERS & LOSERS SUMMARY: Metro Bank Down Amid Mortgage Competition

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 0.9%. The bank reported a rise in third by

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 24 OctoberIndigovisionBeeks FinancialReddePhoto-Me 25 & Smart 26 29 30

Scancell Well Placed To Keep Pushing Forward Cancer Treatment Work

LONDON (Alliance News) - Immunotherapy firm Scancell Holdings PLC on Tuesday said it is well funded to progress its range of proposed cancer immunotherapies.Scancell is developing for based

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 19 September KingfisherHalf Year ResultsBabcock InternationalTrading Year Year

Hygea VCT Net Asset Value Shrinks In First Half On Portfolio Value

LONDON (Alliance News) - Hygea VCT PLC on Tuesday said net asset value decreased in the first half of its current financial year due to a fall in value of its AIM-listed portfolio in the venture a

Scancell To Receive European Patent For Moditope Platform In June

LONDON (Alliance News) - Scancell Holdings PLC on Wednesday said it will secure a European patent for its Moditope immunotherapy platform in mid-June.The cancer treatment developer said the

Scancell Holdings Raises GBP1.2 Million Via Share Open Offer (ALLISS)

LONDON (Alliance News) - Scancell Holdings PLC said Tuesday that it has raised GBP1.2 million through an open offer of 10.1 million shares at a price of 12.0 pence per share.Shares in the a

Hygea VCT Increases NAV Per Share, Changes RBS Overdraft To Loan

LONDON (Alliance News) - Hygea VCT PLC said on Thursday its net present value per share increased in the recent quarter.At March 31, Hygea's NAV per share was 64.4p, up from 63.8p at of

UPDATE: Scancell Raises GBP7.5 Million, Makes Antibody Acquisition (ALLISS)

LONDON (Alliance News) - Immunotherapy developer Scancell Holdings PLC said Wednesday that it raised GBP7.5 million via a placing of 57.4 million shares and a subscription of 5.0 million shares at

Scancell Announces GBP8 Million Fundraise, Makes Antibody Acquisition (ALLISS)

LONDON (Alliance News) - Immunotherapy developer Scancell Holdings PLC said Wednesday that it will raise up to GBP8.0 million via equity issue and also announced a technology shares were down 20%

Scancell Signs Manufacturing Agreement With PolyPeptide Group

LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC said on Tuesday it has signed a manufacturing agreement with therapeutic peptide manufacturer the f T

Oxford Technology Venture Capital Funds Suffer Value Drop

Scancell to develop ImmunoBody lung cancer treatment

(ShareCast News) - Cancer immunotherapy development company Scancell Holdings announced on Monday its intention to develop its SCIB2 ImmunoBody for the treatment of non-small cell lung cancer in combination with a checkpoint inhibitor. The AIM-traded firm's board approved the decision based on the o

Scancell Holdings widens full year loss on US investment

(ShareCast News) - Scancell Holdings, a developer of novel immunotherapies for the treatment of cancer, has reported a third consecutive full year loss due to the costs involved in its expansion in the US. The firm has seen a 3% increase in its operating loss over the last three years. The loss was